Chromosome rearrangements resulting in an increased activation of TERT (telomerase reverse transcriptase) have recently been identified in ~23% of high-stage neuroblastoma with very poor prognosis but no MYCN amplification [44]. This evidence concerns the gene TERT and neuroblastoma.